Anti-ADRP/Perilipin 2 antibody (331-430 aa) [SRM] (STJ11107308)

SKU:
STJ11107308

Current Stock:
Host: Rabbit
Applications: IF/ICC/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Monoclonal
Clone ID: SRM
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.09% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: IF/ICC:1:100-1:400
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: PLIN2
Gene ID: 123
Uniprot ID: PLIN2_HUMAN
Immunogen Region: 331-430 aa
Specificity: A synthetic peptide corresponding to a sequence within amino acids 331-430 of human ADRP/Perilipin 2 (NP_001113.2).
Immunogen Sequence: NIQGVPQNIQDQAKHMGVMA GDIYSVFRNAASFKEVSDSL LTSSKGQLQKMKESLDDVMD YLVNNTPLNWLVGPFYPQLT ESQNAQDQGAEMDKSSQETQ
Tissue Specificity Milk lipid globules.
Post Translational Modifications Acylated.primarily with C14, C16 and C18 fatty acids. Phosphorylation at Tyr-232 by isoform 1 of CHKA (CHKalpha2) promotes dissociation from lipid droplets: dissociation is followed by recruitment of autophagosome machinery to lipid droplets and subsequent lipid droplet lipolysis.
Function Structural component of lipid droplets, which is required for the formation and maintenance of lipid storage droplets.
Protein Name Perilipin-2
Adipophilin
Adipose Differentiation-Related Protein
Adrp
Database Links Reactome: R-HSA-1989781
Reactome: R-HSA-9613354
Reactome: R-HSA-9613829
Reactome: R-HSA-9615710
Cellular Localisation Membrane
Peripheral Membrane Protein
Lipid Droplet
Alternative Antibody Names Anti-Perilipin-2 antibody
Anti-Adipophilin antibody
Anti-Adipose Differentiation-Related Protein antibody
Anti-Adrp antibody
Anti-PLIN2 antibody
Anti-ADFP antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance